Description: Lupuzor, a potential breakthrough treatment for Lupus
aim (553) fda (359) lupus (132) lse (64) sle (40) london stock exchange (25) phase 3 (13) phase iii (9) systemic lupus erythematosus (4) immupharma (1)
ImmuPharma plc is a drug discovery and development group focusing on novel drugs to treat serious medical conditions with a high unmet need.